INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MB
Mulroy BrianChief Financial Officer
SEMRSEMrush Holdings, Inc.
Tax withholding
F$47K
3,941 sh
Apr 10, 2026Apr 13, 2026
Page 978 of 1737
← PrevNext →
traded Apr 10, 2026
+3d
SEC Form 4

Evidence

9
NE
Nierenberg EricEVP, CFO AND TREASURER
CRAICRA INTERNATIONAL, INC.
Grant or award
A—
911 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
WM
Worthington MarkGENERAL COUNSEL and CCO
LONALeonaBio, Inc.
Grant or award
A—
300.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
DW
Dreiling Richard WDirector
ARMKAramark
Grant or award
A$27K
641 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
LR
Lagano RoxanneExecutive Vice President
ZTSZoetis Inc.
Grant or award
A$22K
551 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
CG
Creed GregDirector
ARMKAramark
Grant or award
A$34K
787 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
HM
Holmes Chad MEVP AND CHIEF CORP DEV OFFICER
CRAICRA INTERNATIONAL, INC.
Grant or award
A—
1,579 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
QI
Quain Mitchell IDirector
ALOTAstroNova, Inc.
Grant or award
A—
3,007 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
CH
Chen Feng-HuaChief Operating Officer
NCRANOCERA, INC.
Grant or award
A—
100.0K sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

9
FJ
Ferran Astorga JeannetteExecutive Vice President
ZTSZoetis Inc.
Grant or award
A$198
5 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
SV
Sankarlingam VelchamyPres. of Engineering & Product
ZMZoom Communications, Inc.
Option exercise
M—
4,845 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
BZ
Botelho Kiersten ZazaChief Legal Officer & CCO
HTGCHercules Capital, Inc.
Tax withholding
F$15K
1,018 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
GD
Gray James DChief Financial Officer
LWLamb Weston Holdings, Inc.
Grant or award
A—
7,644 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
WM
Wirfel MichelleEVP, Chief Operating Officer
BCALCalifornia BanCorp \ CA
Tax withholding
F$2,831
154 sh
Apr 12, 2026Apr 13, 2026
traded Apr 12, 2026
+1dSEC Form 4

Evidence

9
ZH
Zhuang HuiyingDirector
NCRANOCERA, INC.
Grant or award
A—
100.0K sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

9
GD
Gray James DChief Financial Officer
LWLamb Weston Holdings, Inc.
Grant or award
A—
99.7K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
SI
Solomon Lance I.Chief Product Officer
MYNDMynd.ai, Inc.
Tax withholding
F$3,414
10.7K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
YD
Yellin Jonathan DEVP AND GENERAL COUNSEL
CRAICRA INTERNATIONAL, INC.
Grant or award
A—
1,396 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
GD
Gray James DChief Financial Officer
LWLamb Weston Holdings, Inc.
Grant or award
A—
99.7K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
FA
Filson Sean AndrewDirector
NCRANOCERA, INC.
Grant or award
A—
100.0K sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

9
LE
Laughter John EEVP & Chief of Operations
DALDELTA AIR LINES, INC.
Option exercise
M—
13.5K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
LE
Laughter John EEVP & Chief of Operations
DALDELTA AIR LINES, INC.
Option exercise
M—
9,080 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
OR
O'Loan RonanChief Human Resources Officer
MYNDMynd.ai, Inc.
Tax withholding
F$2,521
7,877 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
FC
Follmann ChristianChief Operating Officer
HTGCHercules Capital, Inc.
Tax withholding
F$20K
1,365 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
SJ
San Martin JavierCHIEF MEDICAL OFFICER
LONALeonaBio, Inc.
Grant or award
A—
350.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

8
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$80K
1,703 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

8
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Open-market sale · 10b5-1 plan
SELL$185K
60.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

7
HR
Howard Justyn RussellDirector, Executive Chair, 10% Owner
SPTSprout Social, Inc.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

6
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$59K
2,170 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

5
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Option exercise · 10b5-1 plan
M$384K
35.7K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

5
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
251.8K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

5
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
251.8K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

5
FL
Freemen-Bosworth LaurenEVP/Gen Counsel & Corp Sec
PBIPITNEY BOWES INC /DE/
Open-market sale · 10b5-1 plan
SELL$7,970
693 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

5
RR
Renninger RobertCHIEF FINANCIAL OFFICER
LONALeonaBio, Inc.
Grant or award
A—
300.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

4
PC
Perducat CyrilSVP, Chief Technology Officer
ROKROCKWELL AUTOMATION, INC
Option exercise · 10b5-1 plan
M—
581 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

4
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
3,093 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

3
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Option exercise · 10b5-1 plan
M—
38.1K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

3
EM
Erlinger Joseph M.President, McDonald's USA
MCDMCDONALDS CORP
Option exercise · 10b5-1 plan
M—
2,626 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

3
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Derivative conversion · 10b5-1 plan
C—
42.4K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence